Press Releases

Lausanne, Switzerland – There is currently no cure for Alzheimer’s disease and other dementias. The main barriers to the development of effective treatments for Alzheimer’s disease are an incomplete understanding of the disease, fragmented resources, and challenges with the design and implementation of clinical trials.  Experts gathered at a two day meeting in Lausanne to discuss future steps to address dwindling product pipelines and to increase the productivity of drug development processes.

Washington, DCOn November 14, 2014, a star cast will take the stage for a special ensemble reading of Act 1 of Surviving Grace, an original play by comedy writer Trish Vradenburg (“Designing Women,” “Family Ties,” “Kate and Allie”), co-founder of USAgainstAlzheimer’s, a national advocacy organization committed to stopping Alzheimer’s by 2020.  

Washington, DC— A pioneering online health study to assess the cognitive toll of Alzheimer’s and dementias caregiving using online brain performance tests was officially announced today at a ReACT/AARP event. Employers from more than 75 corporations, academic institutions, non-profits and government attended the event, which was held at AARP’s Washington, DC headquarters.

Washington, DC – African Americans are two to three times more likely to develop Alzheimer’s disease than white Americans, yet they are less likely to be diagnosed. While Alzheimer’s is the sixth leading cause of death in the United States, it is the fourth leading cause of death for older African Americans. Alzheimer’s is the only disease in the top ten that currently has no cure, treatment, or prevention.

Washington, DC – George Vradenburg, founder of USAgainstAlzheimer’s and convener of the Global CEO Initiative on Alzheimer’s Disease, released the following statement in recognition of World Alzheimer’s Day. Vradenburg is also a member of the Advisory Council on Research, Care and Services to the U.S.

Pages

^ Back to Top